世界の傷跡治療市場予測2022年-2027年

【英語タイトル】Scar Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが出版した調査資料(IMARC22OT0288)・商品コード:IMARC22OT0288
・発行会社(調査会社):IMARC
・発行日:2022年8月22日
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,499 ⇒換算¥369,852見積依頼/購入/質問フォーム
Five UserUSD3,499 ⇒換算¥517,852見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥665,852見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

IMARC社は、世界の傷跡治療市場規模が2021年131億ドルから2027年212億ドルまで拡大し、2022年から2027年までの年平均成長率は9.1%になると予測しています。本調査レポートでは、傷跡治療の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品/治療タイプ別(局所製品、レーザー治療、表面処理、注射剤)分析、傷タイプ別(萎縮性瘢痕、肥厚性&ケロイド瘢痕、拘縮瘢痕、その他)分析、エンドユーザー別(病院、クリニック、小売薬局、その他)分析、地域別(アジア太平洋、北米、ヨーロッパ、中南米、中東・アフリカ)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格指標、競争状況などの項目をまとめています。なお、本書には、Alliance Pharma PLC, AVITA Medical Ltd., Bausch Health Companies Inc., Cutera, Inc., Establishment Labs SA, GC Aesthetics PLC, Hologic Inc., Mölnlycke Health Care AB, Smith & Nephew PLC and Sonoma Pharmaceuticals Incどの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の傷跡治療市場規模:製品/治療タイプ別
- 傷跡用局所製品の市場規模
- 傷跡レーザー治療の市場規模
- 傷跡表面処理の市場規模
- 傷跡用注射剤の市場規模
・世界の傷跡治療市場規模:傷タイプ別
- 萎縮性瘢痕治療の市場規模
- 肥厚性&ケロイド瘢痕治療の市場規模
- 拘縮瘢痕治療の市場規模
- その他傷跡治療の市場規模
・世界の傷跡治療市場規模:エンドユーザー別
- 病院における市場規模
- クリニックにおける市場規模
- 小売薬局における市場規模
- その他エンドユーザーにおける市場規模
・世界の傷跡治療市場規模:地域別
- アジア太平洋の傷跡治療市場規模
- 北米の傷跡治療市場規模
- ヨーロッパの傷跡治療市場規模
- 中南米の傷跡治療市場規模
- 中東・アフリカの傷跡治療市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格指標
・競争状況

The global scar treatment market size reached US$ 13.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 21.2 Billion by 2027, exhibiting a growth rate (CAGR) of 9.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Scar treatment refers to the techniques and procedures employed for the remedy of acne, keloid, contracture, hypertrophic scars, etc. Scars are visible wound marks caused by surgeries, injuries or infections. The treatment and revision procedures are employed to minimize the appearance of these scars so that they look more consistent with the surrounding skin tone and texture. In order to speed up the healing process, various treatments are used, including over the counter (OTC) gels, ointments, creams, silicone sheets; surgeries for skin grafts, excisions or laser treatment; and collagen injections. In some cases, topical creams enriched with Vitamin E are also applied to diminish post-surgery scars.

The increasing prevalence of skin diseases, along with the rising consumer awareness regarding various scar treatment options, represent as the key factors driving the growth of the market. The growing aesthetic sense among the masses has led to the widespread adoption of skin treatment procedures. Furthermore, enhanced accessibility to dermatological facilities and the introduction of products containing both chemical and herbal ingredients are boosting the overall demand for the service. Dermatological clinics offer precise and latest technological procedures for cosmetic surgeries that provide effective results and cause minimal discomfort to the patient. Additionally, surgeries conducted using laser instruments are used for reducing the visibility of scars after critical injuries. These surgeries also speed up the healing process while ensuring a painless experience for the patient. Other factors, such as rising urbanization, inflating disposable incomes and the increase in affluent population, aggressive promotional activities by service providers and the introduction of organic and natural products, are projected to drive the market in the upcoming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global scar treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product or treatment type, scar type and end-user.

Breakup by Product or Treatment Type:

Topical Products
Gels
Creams
Oils
Sheets
Others
Laser Treatment
Surface Treatment
Injectables

Breakup by Scar Type:

Atrophic Scars
Hypertrophic and Keloid Scars
Contracture Scars
Others

Breakup by End-User:

Hospitals
Clinics
Retail Pharmacies
Others

Breakup by Region:

Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others

Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Alliance Pharma PLC, AVITA Medical Ltd., Bausch Health Companies Inc., Cutera, Inc., Establishment Labs SA, GC Aesthetics PLC, Hologic Inc., Mölnlycke Health Care AB, Smith & Nephew PLC and Sonoma Pharmaceuticals Inc., etc.

Key Questions Answered in This Report:
How has the global scar treatment market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global scar treatment market?
What is the breakup of the market based on the product or treatment type?
What is the breakup of the market based on the scar type?
What is the breakup of the market based on the end-user?
What are the key driving factors and challenges in the market?
What is the structure of the global scar treatment market and who are the key players?
What is the degree of competition in the market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Scar Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product or Treatment Type
6.1 Topical Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Gels
6.1.2.2 Creams
6.1.2.3 Oils
6.1.2.4 Sheets
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Laser Treatment
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Surface Treatment
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Injectables
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Scar Type
7.1 Atrophic Scars
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hypertrophic and Keloid Scars
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Contracture Scars
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Retail Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 Asia Pacific
9.1.1 China
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Japan
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.1.3 India
9.1.3.1 Market Trends
9.1.3.2 Market Forecast
9.1.4 South Korea
9.1.4.1 Market Trends
9.1.4.2 Market Forecast
9.1.5 Australia
9.1.5.1 Market Trends
9.1.5.2 Market Forecast
9.1.6 Indonesia
9.1.6.1 Market Trends
9.1.6.2 Market Forecast
9.1.7 Others
9.1.7.1 Market Trends
9.1.7.2 Market Forecast
9.2 North America
9.2.1 United States
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Canada
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Argentina
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.4.4 Colombia
9.4.4.1 Market Trends
9.4.4.2 Market Forecast
9.4.5 Chile
9.4.5.1 Market Trends
9.4.5.2 Market Forecast
9.4.6 Peru
9.4.6.1 Market Trends
9.4.6.2 Market Forecast
9.4.7 Others
9.4.7.1 Market Trends
9.4.7.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Turkey
9.5.1.1 Market Trends
9.5.1.2 Market Forecast
9.5.2 Saudi Arabia
9.5.2.1 Market Trends
9.5.2.2 Market Forecast
9.5.3 Iran
9.5.3.1 Market Trends
9.5.3.2 Market Forecast
9.5.4 United Arab Emirates
9.5.4.1 Market Trends
9.5.4.2 Market Forecast
9.5.5 Others
9.5.5.1 Market Trends
9.5.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Alliance Pharma
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AVITA Medical Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cutera Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Establishment Labs SA
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 GC Aesthetics PLC
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Hologic Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Mölnlycke Health Care AB
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Smith & Nephew PLC
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sonoma Pharmaceuticals Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials



★調査レポート[世界の傷跡治療市場予測2022年-2027年] (コード:IMARC22OT0288)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の傷跡治療市場予測2022年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆